Sort   by:  
 Page size 
UnknownPathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome.
Not available
S-EPMC8273149 | biostudies-literature
UnknownThrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.
Not available
S-EPMC10439444 | biostudies-literature
UnknownGenome-wide studies define new genetic mechanisms of IgA vasculitis.
Not available
S-EPMC11482997 | biostudies-literature
UnknownGenome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.
Not available
S-EPMC11824687 | biostudies-literature
UnknownBiodiversity impacts of the 2019-2020 Australian megafires.
Not available
S-EPMC11602714 | biostudies-literature
UnknownEstimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study.
Not available
S-EPMC7571362 | biostudies-literature
UnknownEffect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8941448 | biostudies-literature
UnknownGlobal burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12535838 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
Sort   by:  
 Page size